The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: tenofovir     Quarter: 2016Q3

Total Records: 439     Number of Pages: 22

DRUGNAME PT EventCount
TENOFOVIR LAMIVUDINE Meningomyelocele 1
Tenofovir/Emtricitabine Acute kidney injury 1
Tenofovir/Emtricitabine Ankyloglossia congenital 1
Tenofovir/Emtricitabine Bronchial carcinoma 1
Tenofovir/Emtricitabine Crohn's disease 1
Tenofovir/Emtricitabine Dehydration 1
Tenofovir/Emtricitabine Ectopic pregnancy 1
Tenofovir/Emtricitabine Exomphalos 1
Tenofovir/Emtricitabine Gastroenteritis 1
Tenofovir/Emtricitabine Haemangioma 1
Tenofovir/Emtricitabine Hypokalaemia 1
Tenofovir/Emtricitabine Mass 1
Tenofovir/Emtricitabine No adverse event 1
Tenofovir/Emtricitabine Pericardial effusion 1
Tenofovir/Emtricitabine Poisoning 1
Tenofovir/Emtricitabine Pre-eclampsia 1
Tenofovir/Emtricitabine Pulmonary embolism 1
Tenofovir/Emtricitabine Pulmonary tuberculosis 1
Tenofovir/Emtricitabine Syndactyly 1
Tenofovir/Emtricitabine Talipes 1

Total Records: 439     Number of Pages: 22